Building access to the Regenstrief Institute is currently restricted. More on our coronavirus precautions.
See our coronavirus precautions.

Regenstrief Research Scientist and Indiana University School of Medicine Assistant Professor Andrew Gonzalez, M.D., J.D., MPH, has been selected as the 2021-2023 National Academy of Medicine (NAM) Omenn Fellow. He is the first Regenstrief faculty member and only the second from IU School of Medicine to be a NAM fellow.

NAM fellowships enable talented, early-career scholars combining biomedical science and population health to participate actively in the work of the NAM and National Academies of Sciences, Engineering, and Medicine (the National Academies). The fellowships aim to foster a cadre of physician-scientists who will integrate biomedical research, population health, and health policy and will expand the nation’s capacity for research, leadership, and policy development that advances health. The fellows will collaborate with eminent researchers, policy experts, and clinicians from across the country.

Dr. Gonzalez is the inaugural associate director for data science at the Center for Health Services Research at Regenstrief Institute. He is a vascular surgeon studying the quality of and disparities in surgical outcomes for vulnerable populations and ways to improve them. His current early career development project seeks to apply artificial intelligence and machine learning toward optimizing outcomes and value in peripheral arterial disease.

The Omenn Fellowship is awarded for a two-year period and is one of five NAM fellowships. Dr. Gonzalez will be assigned to a board of the National Academies and participate in the board’s activities, including contributing to its reports. A flexible research grant will be awarded to every fellow.

The Gilbert S. Omenn Fellowship was established in 2012 through an endowment from Gilbert S. Omenn, M.D., PhD, and Martha Darling. Dr. Omenn is a physician-scientist at the University of Michigan Medical School whose career bridges biomedical research, public health and public policy, and this fellowship reflects the integrative role that is emblematic of his professional achievements.

About Regenstrief Institute

Founded in 1969 in Indianapolis, the Regenstrief Institute is a local, national and global leader dedicated to a world where better information empowers people to end disease and realize true health. A key research partner to Indiana University, Regenstrief and its research scientists are responsible for a growing number of major healthcare innovations and studies. Examples range from the development of global health information technology standards that enable the use and interoperability of electronic health records to improving patient-physician communications, to creating models of care that inform practice and improve the lives of patients around the globe.

Sam Regenstrief, a nationally successful entrepreneur from Connersville, Indiana, founded the institute with the goal of making healthcare more efficient and accessible for everyone. His vision continues to guide the institute’s research mission.

About IU School of Medicine

IU School of Medicine is the largest medical school in the U.S. and is annually ranked among the top medical schools in the nation by U.S. News & World Report. The school offers high-quality medical education, access to leading medical research and rich campus life in nine Indiana cities, including rural and urban locations consistently recognized for livability.

About Andrew Gonzalez, M.D., J.D., MPH

In addition to his role as a research scientist at Regenstrief, Andrew Gonzalez, M.D., J.D., is an assistant professor of surgery at Indiana University School of Medicine.

About the National Academy of Medicine

The National Academy of Medicine, established in 1970 as the Institute of Medicine, is an independent organization of eminent professionals from diverse fields including health and medicine; the natural, social, and behavioral sciences; and beyond.  It serves alongside the National Academy of Sciences and the National Academy of Engineering as an adviser to the nation and the international community.  Through its domestic and global initiatives, the NAM works to address critical issues in health, medicine, and related policy and inspire positive action across sectors.  The NAM collaborates closely with its peer academies and other divisions within the National Academies of Sciences, Engineering, and Medicine.

MEDIA CONTACTS:
John Erickson
Regenstrief Institute
prteam@regenstrief.org
(317) 643-2313
Cindy Fox Aisen
Regenstrief Institute
caisen@regenstrief.org
(317) 843-2275

Related News

Sep 20, 2021 • News
Ethical challenge of healthcare for undocumented immigrants yields clinician moral distress
In one of the first studies to explore clinician moral distress related to the ethically challenging provision of healthcare to undocumented immigrants, researchers from Regenstrief Institute and Indiana University School of Medicine surveyed physicians and nurses to assess their perspectives on treating end-stage renal disease in undocumented immigrants, a condition which Medicare covers for U.S.…
Continue Reading >
Sep 16, 2021 • News
Regenstrief Institute CEO to depart for Vanderbilt University
Peter Embí, M.D., M.S., president and CEO of the Regenstrief Institute, Inc., will leave the institute in December to assume the position of chair of Vanderbilt University Medical Center’s Department of Biomedical Informatics. He also will serve as senior vice president for research and innovation, a newly created position. He will join the Vanderbilt faculty…
Continue Reading >